Le Lézard
Classified in: Health
Subjects: PER, POL

Regulatory Compliance Associates® Inc. Welcomes Neil J. Pankau as Executive Vice President, Pharmaceuticals


PLEASANT PRAIRIE, Wis., May 15, 2019 /PRNewswire/ -- Regulatory Compliance Associates® Inc. (RCA), a life sciences consultancy focused on quality, regulatory, and technical consulting, announces Neil Pankau has joined the organization as Executive Vice President, Pharmaceuticals.

Mr. Pankau brings to his role at RCA more than 25 years of legal, compliance and business experience across regulated industries including pharmaceuticals, biologics, medical devices and dietary supplements.

"Neil has breadth and depth of knowledge and extensive expertise in the area of risk management," said Brian Matye, RCA's Chief Executive Officer. "His ability to help our clients mitigate legal and regulatory risks and navigate regulatory complexities, as well as his history in developing sound regulatory and compliance strategies, make him the ideal addition to the RCA team."

Prior to joining RCA, Mr. Pankau held senior leadership positions, including Chief Compliance Officer, in multiple organizations such as Getinge AB, Baxter International and Walgreens. He earned his Juris Doctor degree from Marquette University School of Law.

"We are very pleased to have Neil on board as a tremendous asset to our life science clients," said Matye.

About Regulatory Compliance Associates
Regulatory Compliance Associates® Inc. (RCA) provides worldwide services to the life science industry for resolution of compliance and regulatory challenges. We are used to working on the front lines of R&D, operations, regulatory affairs, quality and manufacturing, and we thrive in the scrutiny of the FDA-and globally-regulated industries. As your partners, we can negotiate the potential minefield of regulatory compliance with insight, hindsight, and the clear advantage of our unique expertise and experience.  For more information, visit www.rcainc.com.

SOURCE Regulatory Compliance Associates Inc.


These press releases may also interest you

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 19:54
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...

at 19:52
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...

at 19:22
Product: Instant Noodle Issue: Food - Allergen - Peanut Distribution: AlbertaBritish ColumbiaOntario See the affected products and product photos for this recall Company information Five Continents International Ltd. Telephone: 416-292-6766| Fax:...

at 18:45
The Samaritan's Purse DC-8 departed our hangar in Greensboro, North Carolina, yesterday morning, with a 13-member Disaster Assistance Response Team (DART) and 24 tons of life-saving relief for hurricane-devastated residents of Grenada in the south...



News published on and distributed by: